# FDA recall D-0177-2021

> **Imprimis NJOF, LLC** · Class II · drug recall initiated 2020-12-17.

## Product

Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979

## Reason for recall

Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-0177-2021
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-12-17
- **Report date:** 2021-01-06
- **Termination date:** 2023-08-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0177-2021

## Citation

> AI Analytics. FDA recall D-0177-2021. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0177-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*